Wiseneuro is a company headquartered in Italy.
Wiseneuro is a startup founded in 2021 as a spin-off of the Italian Institute of Technology in Genoa developing drugs for neurological diseases, including treatments targeting symptoms associated with Down syndrome, autism spectrum disorders, epilepsy, and rare neurodevelopmental diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.